Replies to post #961 on Lineage Cell Therapeutics Inc (LCTX)

[Cincinnatus]

New information.

Renelon..."initially develop as a topically-administered device" Never saw the "topically-administered" before and I'm glad to see they're going the 501(k) route. If approved in the typical 6 - 12 month time span, there could be some revenue opportunities much earlier than the typical new biotech.

And anyone know the revenue figures for LifeMap or Cytiva?? Never heard of Cytiva before??